Womble Carlyle attorney Tom Cawley has been named to Intellectual Asset Management magazine’s IAM Patent 1000: The World’s Leading Patent Practitioners for 2017.

In addition, the IAM Patent 1000 report recognizes Womble Carlyle as a top firm for patent law in Georgia and North Carolina.

The IAM Patent 1000 is an annual guide to the leading patent practitioners in 50 jurisdictions around the globe. Researchers spent five months interviewing patent attorneys and the buyers of their legal services to determine the IAM Patent 1000 for 2017. Ranked attorneys do not pay to be listed in the IAM Patent 1000.

Tom Cawley’s practice focuses on biotechnology patent prosecution, opinion work, and client counseling, including the design and implementation of global intellectual property strategies. Dr. Cawley has experience in a wide range of technologies, including gene therapy, transgenic animals, genomics, recombinant herpes simplex viruses, recombinant production of procaryotic and eucaryotic gene products, small molecule technologies, antibody technologies, novel adjuvant therapies, screening methods for the identification of novel drug candidates, cancer therapy, and methods and compositions for the treatment of a variety of neurological conditions. He practices in the firm's Northern Virginia office.